Inventor
VANMECHELEN EUGEEN
BE16 patents
⚠️ This page may combine multiple inventors who share the name “VANMECHELEN EUGEEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INNOGENETICS NV
12 patentsUS6238892B1May 29, 2001
Monoclonal antibodies directed against the microtubule-associated protein tau
INNOGENETICS NV84 citations97
US6010913AJan 4, 2000
Isolated human tau peptide
INNOGENETICS NV36 citations95
US5843779ADec 1, 1998
Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies
INNOGENETICS NV51 citations95
US6900293B2May 31, 2005
Monoclonal antibodies directed against the microtubule-associated protein tau
INNOGENETICS NV14 citations92
US6500674B1Dec 31, 2002
Method for the diagnosis of brain/neurological disease using monoclonal antibodies specific for PHF-tau, hybridomas secreting them, and antigen recognition by these antibodies and their applications
INNOGENETICS NV20 citations92
US6232437B1May 15, 2001
Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.
INNOGENETICS NV25 citations92
US6008024ADec 28, 1999
Monoclonal antibodies specific for PHF-tau, hybridomas secreting them, antigen recognition by these antibodies and their applications
INNOGENETICS NV32 citations92
US5861257AJan 19, 1999
Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
INNOGENETICS NV21 citations92
US6680173B2Jan 20, 2004
Diagnosis of tauopathies
INNOGENETICS NV31 citations90
US6670137B2Dec 30, 2003
Differential diagnosis of neurological diseases
INNOGENETICS NV26 citations88
US7387879B2Jun 17, 2008
Diagnosis of tauopathies
INNOGENETICS NV12 citations81
US8343493B2Jan 1, 2013
Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs
INNOGENETICS NV4 citations57